Published online Dec 28, 2020. doi: 10.3748/wjg.v26.i48.7619
Peer-review started: September 28, 2020
First decision: November 8, 2020
Revised: November 19, 2020
Accepted: December 6, 2020
Article in press: December 6, 2020
Published online: December 28, 2020
Processing time: 88 Days and 6.7 Hours
Stress-related gastric mucosal damage is a prevalent complication in critically ill patients in the intensive care unit, and it may evolve to ulceration and bleeding. Stress ulcer prophylaxis has been common in routine intensive care, but with controversy. Co-secreted with mucins, intestinal trefoil factor (ITF) is reported to promote the restitution and regeneration of intestinal mucosal epithelium, but the mechanism is unknown.
As an endogenous peptide, ITF harbors innate advantages over conventional anti-ulcer agents, and might be a new candidate for stress ulcer prophylaxis.
To investigate the protective effects of ITF on gastric mucosa and explore the underlying mechanisms.
We utilized water immersion restraint stress-induced gastric mucosal damage rat model and lipopolysaccharide-induced gastric epithelium cell damage model to investigate the potential functions of ITF on damaged gastric mucosa both in vivo and in vitro.
We found that ITF promoted proliferation and migration and inhibited necrosis of gastric epithelium cells and preserved the integrity of gastric mucosa by increasing expression of occludin and zonula occludens-1. Additionally, pretreatment with ITF ameliorated the gastric mucosal epithelial damage and promoted mucosal repair in vivo. We found that the protective effects of ITF were exerted by activation of Akt signaling, and the specific inhibitor of this pathway, LY249002, abolished the protective effects.
Pretreatment with ITF alleviated stress-induced gastric mucosal damage by activation of Akt signaling.
This study provides insight into the translational potential of ITF as a promising candidate for prevention and treatment of stress-induced gastric mucosal damage.